HVTN 702 was a
clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, diet ...
which the
HIV Vaccine Trials Network organized to develop an
HIV vaccine
An HIV vaccine is a potential vaccine that could be either a preventive vaccine or a therapeutic vaccine, which means it would either protect individuals from being infected with HIV or treat HIV-infected individuals.
It is thought that an HIV ...
. In February 2020 the organizers halted the trial after finding no evidence of efficacy.
Around December 2019 various media outlets reported that HVTN 702 could be an effective vaccine in preventing HIV.
In 2016 various media outlets announced the start of the research.
HVTN 702 was based on outcomes of the
RV 144 trial.
References
{{reflist
External links
profileat
ClinicalTrials.gov
HIV vaccine research
Clinical trials related to HIV